Clinical Trial Update: AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating AL101 for Notch-activated Adenoid Cystic Carcinoma (including metastatic disease) is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• AL101

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING